Hemostatic In Vitro Properties of Novel Plasma Supernatants Produced from Late-storage Low-titer Type O Whole Blood
Emily Mihalko(University of North Carolina at Chapel Hill), Susan M. Shea(University of Iowa), Amudan J. Srinivasan(University of Pittsburgh), Philip C. Spinella, Katelin Rahn(University of Pittsburgh), Matthew D. Neal(University of Pittsburgh), Jansen N. Seheult(Mayo Clinic), Mark H. Yazer(University of Pittsburgh), Darrell J. Triulzi(MACOM (United States))
Cited by 3
Related Papers
Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion
|Cochrane Database of Systematic Reviews|2016|1.2k
Prehospital Plasma during Air Medical Transport in Trauma Patients at Risk for Hemorrhagic Shock
|New England Journal of Medicine|2018|879
Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.
|Bristol Research (University of Bristol)|2021|589
Effects of Red-Cell Storage Duration on Patients Undergoing Cardiac Surgery
|New England Journal of Medicine|2015|486
Liberal versus restrictive transfusion thresholds for patients with symptomatic coronary artery disease
|American Heart Journal|2013|374